Trude Bahloul-Butterfass
Muenster, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 13, 2023
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy.
Journal: Annals of hematology
Published: October 15, 2022
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 15, 2022
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 12, 2018
A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia.
Journal: PloS one
Published: July 13, 2016
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
Journal: The Lancet. Oncology
Published: March 24, 2016
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 03, 2015
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 26, 2014
Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial.
Journal: Dermatology (Basel, Switzerland)
Published: July 04, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026